Pharmapolitics in Russia: Making Drugs and Rebuilding the Nation (SUNY series in National Identities)

Documents the surprising role pharmaceutical science and technology has played in Russia's search for national identity over a century of political turbulence. Over the last one hundred years, the Russian pharmaceutical industry has undergone multiple dramatic transformations, which have taken place alongside tectonic political shifts in society associated with the rise and fall of the Soviet Union and the emergence of a post-Soviet order. Pharmapolitics in Russia argues that different versions of the Russian pharmaceutical industry took shape in a co-productive process, equally involving political ideologies and agendas, and technoscientific developments and constraints. Drawing on interviews, documents, literature, and media sources, Olga Zvonareva examines critical points in the history of the pharmaceutical industry in Russia. This includes the emergence of Soviet drug research and development, the short-lived neoliberal turn of the 1990s, and the ongoing efforts of the Russian government to boost local pharmaceutical innovation, which in turn produced a now widely shared vision of an independent and self-sufficient nation. The resulting industrial organizations and practices, she argues, came to embed and transmit particular imaginaries of the nation and its future. Olga Zvonareva is Assistant Professor of Health, Ethics, and Society at Maastricht University in the Netherlands, as well as an Associate Professor at National Research Tomsk State University and Siberian State Medical University in Russia. She is the coeditor (with Evgeniya Popova and Klasien Horstman) of Health, Technologies, and Politics in Post-Soviet Settings: Navigating Uncertainties Contents Illustrations Acknowledgments Introduction: Drug Development and Politics Accounts of Drug Development Advances in Pharmaceutical Science and Technology Pharmaceuticalization and the Social Life of Drugs Strategic Technopolitical Practices Investigating Pharmapolitics Chapter 1 The Soviet Pharmapolitical Regime The Foundation of the Soviet Pharmapolitical Regime Drugs: From Bench to International Politics Soviet Bioethics: Claiming a Superior Vision of Society Pursuing Pharmapolitics Chapter 2 Neoliberal Experiments in the Post-Soviet State A Neoliberal Vision of the Nation and its Future Clash of Visions Envisioning Freedom A Neoliberal Vision and Pharmaceutical Industry Deregulatory Reforms in the Western Pharmaceutical Sectors The Russian Pharmaceutical Industry: Living through Neoliberal Experiments Rejection Search for Alternatives The Russian Pharmaceutical Industry and Market in 1996 at a Glance Chapter 3 The Arrival of Commercial Clinical Trials in Russia Value of Medical Experimentation Joining the Global Clinical Trials Enterprise Value for Investigators and Academia Information Needs of Investigators and Academic Work Entwining the Academic and the Corporate Value for Patients Ways to Live with Chronic Disease Bridging Research and Treatment Boundary Process Chapter 4 Pharma-2020 Policy Cross-National Differences in Innovative Performance Market and National Security Who Is to Benefit? Relations with the World Independence and Self-Sufficiency Contemporary Russian Pharmaceutical Industry and Market at Glance Chapter 5 Innovation Environment Collaboration and Innovation Who Works Together in Medical Innovation? Challenges for Working Together: Business and Academia Business Academia Definitions and Trajectories of Innovation Continuous Change and Lack of Transparency: State Bringing Everyone Together: Infrastructure for Collaboration Political Culture Russian Drug Innovation Infrastructure in 2018 Chapter 6 Pharmapolitics in Russia and Beyond Constituting Pharmapolitics Markets and Health Needs in Russian Pharmapolitics Oppressing Imagination: Russian and Global Pharmapolitics Notes Bibliography Index __Documents the surprising role pharmaceutical science and technology has played in Russia’s search for national identity over a century of political turbulence.____Pharmapolitics in Russia__